Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 11, 2025 • 12:30 AM ET

Date/Time Source News Release
08/08/2025 08:00 AM EDT GlobeNewswire Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
08/05/2025 07:34 AM EDT GlobeNewswire Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
08/04/2025 07:33 AM EDT GlobeNewswire Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
07/31/2025 07:24 AM EDT GlobeNewswire Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO
07/22/2025 07:00 AM EDT GlobeNewswire Quantum BioPharma Makes Strategic Investment in GameStop Corp.
07/08/2025 08:00 AM EDT GlobeNewswire Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom
06/27/2025 04:30 PM EDT GlobeNewswire Quantum BioPharma Announces Private Placement
06/26/2025 07:30 AM EDT GlobeNewswire Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
06/18/2025 09:19 AM EDT Newsfile Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress
06/17/2025 08:00 AM EDT GlobeNewswire Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital
Page

Additional News

As of August 11, 2025 • 12:30 AM ET

Date/Time Source News Release
08/08/2025 09:45 AM EDT InvestorWire InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) PET Tracer Shows Potential for Monitoring Myelin Integrity in Multiple Sclerosis
08/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Quantum Biopharma Ltd.
08/07/2025 08:31 AM EDT SeekingAlpha Quantum BioPharma GAAP EPS of -$3.23
08/05/2025 09:05 AM EDT InvestorWire InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Positive Phase 1 Safety Results for Lucid-MS
08/04/2025 09:05 AM EDT InvestorWire InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Opposes Motion to Dismiss in $700 Million Market Manipulation Lawsuit
07/31/2025 09:05 AM EDT InvestorWire InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Portfolio Company Unbuzzd Wellness Launches $5 Million Regulation D Offering
07/22/2025 09:25 AM EDT InvestorWire InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Acquires GameStop Shares as Part of Strategic Market Integrity Campaign
07/22/2025 07:15 AM EDT SeekingAlpha Quantum BioPharma makes strategic investment in GameStop
07/08/2025 10:52 AM EDT InvestorWire InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Submits MS Drug Candidate to UK ILAP Program 
07/04/2025 09:49 AM EDT SeekingAlpha Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.